Hepatic epithelioid hemangioendothelioma (HEH) is a rare vascular tumor of the liver with an unpredictable malignant potential. Its growth can lead to hepatic failure, extrahepatic metastasis and death. Surgical resection or liver transplantation is the treatment of choice if metastasis is not identified. Several antineoplastic agents have been proposed for cases of nonresectable HEH. We report the case of a 52-year-old patient with HEH metastatic to the lungs who was successfully treated with oral thalidomide therapy.

Keywords:
Thalidomide, Epithelioid hemangioendothelioma, Angiogenic inhibition, Vascular tumor
1.
Uchimura K, Nakamuta M, Osoegawa M, Takeaki S, Nishi H, Iwamoto H, Enjoji M, Nawata H: Hepatic epithelioid hemangioendothelioma. J Clin Gastroenterol 2001;32:431–434.
2.
Lauffer JM, Zimmermann A, Krahenbuhl L, Triller J, Baer HU: Epithelioid hemangioendothelioma of the liver. A rare hepatic tumor. Cancer 1996;78:2318–2327.
3.
Makhlouf HR, Ishak KG, Goodman ZD: Epithelioid hemangioendothelioma of the liver: A clinicopathologic study of 137 cases. Cancer 1999;85:562–582.
4.
Ishak KG, Sesterhenn IA, Goodman ZD, Rabin L, Stromeyer FW: Epithelioid hemangioendothelioma of the liver: A clinicopathologic and follow-up study of 32 cases. Hum Pathol 1984;15:839–852.
5.
Furui S, Itai Y, Ohtomo K, Yamauchi T, Takenaka E, Iio M, Ibukuro K, Shichijo Y, Inoue Y: Hepatic epithelioid hemangioendothelioma: Report of five cases. Radiology 1989;171:63–68.
6.
Radin DR, Craig JR, Colletti PM, Ralls PW, Halls JM: Hepatic epithelioid hemangioendothelioma. Radiology 1988;169:145–148.
7.
Lyburn ID, Torreggiani WC, Harris AC, Zwirewich CV, Buckley AR, Davis JE, Chung SW, Scudamore CH, Ho SG: Hepatic epithelioid hemangioendothelioma: Sonographic, CT, and MR imaging appearances. AJR Am J Roentgenol 2003;180:1359–1364.
8.
Ruebner BH, Eggleston JC: What is new in epithelioid hemangioendothelioma of the liver? Pathol Res Pract 1987;182:110–112.
9.
Dietze O, Davies SE, Williams R, Portmann B: Malignant epithelioid haemangioendothelioma of the liver: A clinicopathological and histochemical study of 12 cases. Histopathology 1989;15:225–237.
10.
Terg R, Bruguera M, Campo E, Hojman R, Levi D, Podesta A: Epithelioid hemangioendothelioma of the liver: Report of two cases. Liver 1988;8:105–110.
11.
Taege C, Holzhausen H, Gunter G, Flemming P, Rodeck B, Rath FW: Malignant epithelioid hemangioendothelioma of the liver – a very rare tumor in children. Pathologe 1999;20:345–350. (Article in German.)
12.
Nagase M, Ryu M, Kinoshita T, Konishi M, Inoue K, Tiku V, Nawano S: Epithelioid hemangioendothelioma of the liver. J Hepatobiliary Pancreat Surg 2000;7:443–447.
13.
Bamias A, Dimopoulos MA: Angiogenesis in human cancer: Implications in cancer therapy. Eur J Intern Med 2003;14:459–469.
14.
Amato RJ: Thalidomide: An antineoplastic agent. Curr Oncol Rep 2002;4:56–62.
15.
Weiss SW, Enzinger FM: Epithelioid hemangioendothelioma: A vascular tumor often mistaken for a carcinoma. Cancer 1982;50:970–981.
16.
Scoazec JY, Lamy P, Degott C, Reynes M, Feldmann G, Bismuth H, Benhamou JP: Epithelioid hemangioendothelioma of the liver. Diagnostic features and role of liver transplantation. Gastroenterology 1988;94:1447–1453.
17.
Ben-Haim M, Roayaie S, Ye MQ, Thung SN, Emre S, Fishbein TA, Sheiner PM, Miller CM, Schwartz ME: Hepatic epithelioid hemangioendothelioma: Resection or transplantation, which and when? Liver Transpl Surg 1999;5:526–531.
18.
Madariaga JR, Marino IR, Karavias DD, Nalesnik MA, Doyle HR, Iwatsuki S, Fung JJ, Starzl TE: Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol 1995;2:483–487.
19.
Marino IR, Todo S, Tzakis AG, Klintmalm G, Kelleher M, Iwatsuki S, Starzl TE, Esquivel CO: Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation. Cancer 1988;62:2079–2084.
20.
Holley MP, Cuschieri A: Epithelioid haemangioendothelioma of the liver: Objective response to hepatic intra-arterial 5-FU. Eur J Surg Oncol 1989;15:73–78.
21.
Roudier-Pujol C, Enjolras O, Lacronique J, Guillemette J, Herbreteau D, Leibowitch M, Escande JP: Multifocal epithelioid hemangioendothelioma with partial remission after interferon alfa-2a treatment. Ann Dermatol Venereol 1994;121:898–904 (in French).
22.
Manglani M, Chari G, Sharma U, Jog A, Raghavan K, Lokeshwar MR: Successful treatment with cyclophosphamide in a large hepatic hemangioendothelioma. Indian Pediatr 1994;31:875–877.
23.
Idilman R, Dokmeci A, Beyler AR, Bastemir M, Ormeci N, Aras N, Ekinci C, Uzunalimoglu O, De Maria N, Van Thiel DH: Successful medical treatment of an epithelioid hemangioendothelioma of liver. Oncology 1997;54:171–175.
24.
Singhal S, Mehta J: Thalidomide in cancer. Biomed Pharmacother 2002;56:4–12.
© 2004 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.